Yu Deng
Jiangnan University · 46 works · 1,064 citations · h-index 18
Top works
- Petroclostridium xylanilyticum gen. nov., sp. nov., a xylan-degrading bacterium isolated from an oilfield, and reclassification of clostridial cluster III members into four novel genera in a new Hungateiclostridiaceae fam. nov.
- Thermococcoides shengliensis gen. nov., sp. nov., a new member of the order Thermotogales isolated from oil-production fluid
- IMpower010: Primary results of a phase III global study of atezolizumab versus best supportive care after adjuvant chemotherapy in resected stage IB-IIIA non-small cell lung cancer (NSCLC).
- Isolation and characterization ofKeratinibaculum paraultunensegen. nov., sp. nov., a novel thermophilic, anaerobic bacterium with keratinolytic activity
- Lactobacillus panisapium sp. nov., from honeybee Apis cerana bee bread
- Defluviitalea raffinosedens sp. nov., a thermophilic, anaerobic, saccharolytic bacterium isolated from an anaerobic batch digester treating animal manure and rice straw
- Characterization of dissolved organic matter extracted from fermentation effluent of swine manure slurry using spectroscopic techniques and parallel factor analysis (PARAFAC)
- Terrisporobacter petrolearius sp. nov., isolated from an oilfield petroleum reservoir
- Clostridium swellfunianum sp. nov., a novel anaerobic bacterium isolated from the pit mud of Chinese Luzhou-flavor liquor production
- Aminipila luticellarii sp. nov., an anaerobic bacterium isolated from the pit mud of strong aromatic Chinese liquor, and emended description of the genus Aminipila
- Chryseobacterium reticulitermitis sp. nov., isolated from the gut of Reticulitermes aculabialis
- Intravenously administered BMSCs reduce neuronal apoptosis and promote neuronal proliferation through the release of VEGF after stroke in rats
- Clostridium prolinivorans sp. nov., a thermophilic bacterium isolated from an anaerobic reactor degrading propionate
- Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non–Small Cell Lung Cancer (IMpower010): An Open-Label, Randomized, Phase III Trial
- Investigating the spatial variability of dissolved organic matter quantity and composition in Lake Wuliangsuhai
- Hand-Washing: The Main Strategy for Avoiding Hand, Foot and Mouth Disease
- Risk Factors Associated with Dengue Virus Infection in Guangdong Province: A Community-Based Case-Control Study
- Predicting Hepatitis B Virus Infection Based on Health Examination Data of Community Population
- Incorporating longitudinal history of risk factors into atherosclerotic cardiovascular disease risk prediction using deep learning
- IMpower010: Final disease-free survival (DFS) and second overall survival (OS) interim results after ≥5 years of follow up of a phase III study of adjuvant atezolizumab vs best supportive care in resected stage IB-IIIA non-small cell lung cancer (NSCLC).